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Summary
Background: COPD patients have varying degrees of airways disease and emphysema. CT scan-
ning can differentiate these pathological subtypes. We evaluated airway dimensions and
emphysema severity with low dose CT scanning in COPD patients to determine relationships
with clinical features of the disease.
Methods: Fifty six patients with COPD had a low dose thoracic CT scan. Airways were analysed
using novel software as either proximal (1st and 2nd generation) or distal (3rd to 6th genera-
tion); the extent of emphysema was assessed as the percentage of pixels less than 950 Houns-
field units. CT measures were related to clinical features of COPD.
Results: Thicker walls in the proximal airways were associated with clinical features that may
represent a bronchitic phenotype (MRC Bronchitis Score; bZ 0.20, pZ 0.003, Frequent Exac-
erbations; b Z 0.14, p Z 0.017, Total St George’s Score; b Z 0.50, p Z 0.001 and body mass
index [BMI]; b Z 0.26, p Z 0.049); these associations were independent of emphysema. BMI
was negatively correlated with the degree of emphysema (bZ 0.41, pZ 0.001). Airway wall
thickness was negatively correlated with CT measured emphysema for both proximal and more
distal airways (r Z 0.30, p Z 0.025 and r Z 0.32, p Z 0.015).
Conclusions: CT measured airway dimensions are associated with several clinical measures of
COPD; these are related to a bronchitic phenotype and the effect is independent of emphy-
sema.
ª 2010 Elsevier Ltd. All rights reserved.
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Introduction
COPD is a heterogeneous condition in which varying degrees
of both airways disease and emphysema are present. Clin-
ically these pathologies tend to be considered as one,
quantified by the degree of airflow limitation.1 There is
evidence however, that airway remodelling and emphy-
sema develop from different pathogenic mechanisms.2e4 As
future treatments may target these processes separately,5
it is important to characterise patients for both the
extent of airways disease and emphysema. CT scanning can
differentiate these underlying pathological subtypes.6e10
Studies of emphysema have validated CT lung density
measures with both pathology and clinical parameters.11e14
The relationship between CT measurements of airway
dimensions and clinical features of COPD has been less well
examined15e17 and as yet there is no consensus for the best
method of assessment.18
We hypothesised that airway dimensions and emphy-
sema would relate to distinct clinical parameters of the
disease. In this study we investigated the use of novel
software designed to assess both airway dimensions and
emphysema following low dose thoracic CT scanning in
a cohort of COPD patients. We assessed the relationship
between these measures and clinical parameters of the
disease. In addition, we determined whether airway
dimensions were different in patients with or without signs
and symptoms suggestive of airway disease, such as symp-
toms of chronic bronchitis or increased exacerbation
frequency.
Methods
Study patients
Current and ex-smokers with a clinical diagnosis of COPD
were recruited from primary care and through a respiratory
outpatient clinic at the Royal Infirmary of Edinburgh.
Chronic airflow limitation was confirmed as a post bron-
chodilator FEV1/FVC ratio less than 0.7.
1 Patients were
studied when clinically stable; at least six weeks post-
exacerbation. Subjects with other respiratory conditions,
systematic inflammatory diseases or prescribed regular oral
corticosteroids were excluded. Fifty six patients were
recruited. All studies were performed with the approval of
Lothian Regional Ethics Committee, and written informed
consent was obtained from all subjects.
Study design
A structured questionnaire was administered by trained
healthcare staff to record baseline characteristics including
past medical history and smoking status. Chronic bronchitis
was defined using the MRC chronic bronchitis questionnaire,
breathlessness with the MRC dyspnoea score, and health
related quality of life using the St George’s Respiratory
Questionnaire (SGRQ). Exacerbation frequency was
assessed by patient recall over a one year period: an
exacerbation was defined as an increase in symptoms
requiring a course of corticosteroids or antibiotics.19
Patients were classified as frequent (two or more per
year) or infrequent exacerbators. Patients performed
a 6 min walking test according to ATS guidelines.20
Spirometry was performed in triplicate (Vitalograph,
Ennis, Ireland) with reversibility to salbutamol (2.5 mg
nebulised). Height and weight were measured to calculate
body mass index (BMI).
CT acquisition
Study subjects had a low dose thoracic CT scan at full
inspiration. Patients were coached to achieve total lung
capacity. A 16 slice Toshiba Aquilion CT scanner (Toshiba
Medical Systems, Tokyo, Japan) was used with the following
parameters: 135 kV, 40 mA, rotation time 0.5 s, 16  1 mm
collimation, pitch 1.45, reconstructed at 2.5 mm intervals
with 5 mm thick slices (for lung density analysis) and at
1 mm intervals with 1 mm slices (for airway measurement).
The Hounsfield Unit (HU) for air was recalibrated using
a method similar to that described by Stoel et al21 to
correct for the air offset in Toshiba CT scanners (which is
approximately 985 HU instead of the nominal 1000 HU).
All CT scans were reviewed by an experienced chest radi-
ologist (JTM); on visual assessment any scans with other
lung conditions (eg bronchiectasis, interstitial lung disease)
resulted in exclusion of the patient from the study.
CT image reconstruction and analysis
Software was developed to assess airway wall dimensions.
A path was plotted by specifying landmarks at selected
points along an airway and linked with a smooth 3D spline
curve (Fig. 1). To maximise airway data for analysis,
airways were measured from the most proximal 1st gener-
ation out to the 6th generation distally which is at the
limitation of our low dose technique. Airway profiles were
then generated on cross-sections orthogonal to this airway
path and measurements taken at 1 mm intervals. Rays were
projected radially from a seed point at the centre of the
lumen (Fig. 2). Using the full width at half maximum
(FWHM) technique22,23 the average airway wall thickness
was calculated from portions of the wall surrounding the
lumen which had been accepted as valid (ie areas with
adjacent blood vessels were automatically excluded,
Fig. 2). The lumen wall was detected as the inner half
maximum and an ellipse fit to calculate lumen area. Wall
thickness was added to the lumen ellipse major and minor
axes to calculate the relative areas of lumen and airway
wall. The percentage wall area was defined as %
WA Z (outer area of airway e lumen area)/outer area of
airway  100. %WA was measured for two airways to the 6th
generation; one in the right upper lobe via the apical
segment bronchus and one in the right lower lobe via the
posterior basal segment bronchus. The segmental bronchi
of these airways were considered third generation as
described by Boyden.24 A mean of the upper and lower
airway dimensions was taken for each of the 2nd to 6th
generations; this was done to reduce the effect of distri-
butional differences in disease and to limit the potential for
inducing Type 1 errors in the results. Airway generations
were designated as proximal (1st and 2nd) or distal (3rd to
6th) and a mean %WA for each group calculated for anal-
ysis. This designation was defined by airway luminal
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diameter in order to differentiate large proximal airways
(mean diameter 11.0e14.7 mm) from the smaller more
distal airways (mean diameter 4.1e1.9 mm) whose dimen-
sions were clearly very different (Table 3). This approach
had the added benefit of simplifying subsequent analysis.
The number of pixels below 950 Hounsfield Units was
used to quantify low attenuation areas (LAA) as a measure
of emphysema. Software was developed to calculate the
percentage of pixels below this threshold (%LAA) from the
total number within lung parenchyma for each lung CT scan
as previously described.25
Phantom validation and reproducibility
The validity of our software to make accurate measure-
ments and the reliability and reproducibility of these
measurements were independently tested prior to clinical
studies. Further details and results of this work are
contained within the online supplement.
Statistics
%LAA had a skewed distribution and was thus log trans-
formed. Continuous data were analysed with Pearson’s
correlation coefficient if normally distributed, otherwise
Spearman’s rank test was used. Dichotomous data were
analysed with an independent samples t-test.
Multiple regression modelling was used to test for inde-
pendent associations in all cases where a significant
univariate correlation was found between airway dimen-
sions and clinical measures of disease. For analysis of
chronic bronchitis and frequency of exacerbations, binary
logistic regression was used. In all other cases, multiple
linear regression modelling was used.
In all statistical analyses, significance was taken as
p < 0.05.
Results
In our cohort of 56 COPD patients there was a range of
clinical disease severity, demonstrated in Table 1.
Regarding airway dimensions (Table 2); luminal diameter
and airway wall thickness decreased from the 1st to 6th
generation distally, while percentage wall area (%WA)
increased. Only the 6th generation of airways demon-
strated a mean luminal diameter less than 2 mm. The
datasets for the 5th and 6th generation of airway are
incomplete (n Z 52 and n Z 35, respectively); for a small
subset of patients these distal airways could not be ana-
lysed, they were either destroyed by emphysematous
changes or else the lumen was not identified. In Table 2,
data are provided as a mean of upper and lower lobe
airways; separate analysis of upper and lower airways did
not alter the results.
To assess associations between CT measures and clinical
features, airway generations have been grouped as prox-
imal (1st and 2nd) or distal (3rd to 6th). A strong negative
correlation was found between %WA and emphysema
severity (%LAA) in both the larger proximal and smaller
distal airways (Table 3).
Several clinical measures of disease were found to
correlate significantly with %WA in the proximal airways.
Emphysema severity had strong negative associations with
both FEV1 % predicted and BMI. There were no significant
Figure 1 Plotted airway path linked by smooth 3D spline curve.
Airway dimensions in COPD 1685
univariate relationships with clinical parameters identified
in an analysis using the distal airways.
Further analysis of St George’s Respiratory Question-
naire (SGRQ) data demonstrated that the Symptoms and
Impact components were associated with an increase in %
WA in the proximal airways (r Z 0.45, p Z 0.001 and
r Z 0.35, p Z 0.009, respectively).
The clinical measures of COPD that had significant
univariate associations with %WA in the proximal airways
were used as dependent variables in multiple regression
models. Proximal airway %WA, emphysema severity (%LAA),
age, sex, and height were used as independent variables
(Table 4). Despite the negative correlation identified
between proximal airway %WA and %LAA (Table 3), there
was no evidence of confounding as tested with collinearity
diagnostics (data not shown). After adjusting for
confounders including age and sex, both thicker airway
walls and more severe emphysema were independently
associated with total SGRQ score. Interestingly, BMI was
negatively associated with emphysema and positively
associated with airway wall thickness. In contrast, airway
wall thickness was independently associated with frequent
exacerbations and symptoms of chronic bronchitis, with
only trends to an association with emphysema severity.
Discussion
The development of techniques to assess airway wall
dimensions and measure emphysema severity in COPD using
CT scanning may be important for both researchers and
clinicians in charting the progression of disease and
response to treatment. In this study, we have shown that
patients with symptoms of chronic bronchitis and patients
with frequent exacerbations have thicker airway walls than
those without, independent of emphysema severity.
Table 1 Demographic data and clinical features.
Mean  standard deviation shown for continuous variables.
n 56
Male sex 41 (73%)
m 67  9
FEV1 %predicted 52  18
FVC %predicted 81  21
FEV1/FVC 48  13
Smoking, pack years 47  17
Body mass index,a kg/m2 26 (22e31)
Six minute walking distance, metres 367  122
St George’s Respiratory Questionnaire,
total score
46  20
Frequent Exacerbators, 2/year 30 (54%)
MRC Dyspnoea Score 1 5 (9%)
2 19 (34%)
3 16 (29%)
4 15 (27%)
5 1 (2%)
Symptoms of chronic bronchitis 27 (51%)
a Denotes non-parametric distribution: median (interquartile
range). n (%) shown for dichotomous variables.
Figure 2 Measuring wall thickness on airway profile using the FWHM technique. Note wall area with adjacent blood vessel has
been excluded.
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Additionally, both severity of emphysema and airway wall
thickness are independently associated with poorer health
related quality of life, as measured by the St George’s
Respiratory Questionnaire. Finally, body mass index is
positively associated with airway wall thickness, whereas it
is negatively associated with emphysema severity. These
novel findings suggest that we may be able group individ-
uals into clinically useful CT-defined phenotypes according
to their airway wall dimensions and emphysema severity.
Crucially, unlike much of the other work in this area, we
have adjusted for potential confounders, including age and
sex, in our analyses. This is especially important given the
well described association between age and reduction in
lung density and the known gender differences in emphy-
sema distribution,25,26 and more recently, airway wall
thickness.27,28
Using a low-dose CT scan, we have utilised novel soft-
ware to assess airway dimensions. Both lumen diameter and
airway wall thickness reduce from proximal to distal
airways. However, the proportion of airway wall thickness
to lumen diameter, percentage wall area (%WA), increases
from proximal to distal airways. We grouped proximal
airways (1st and 2nd generation) with similar luminal
diameter/wall thickness and distal airways (3rd to 6th
generation) to reduce variability and to simplify analysis.
We have shown several associations between the proximal
airways and clinical features of COPD. These associations
were not found with distal airways. The relationships
between airway wall thickness and symptoms of chronic
bronchitis, frequent exacerbations and body mass index
indicate that measurement of airway walls may allow us to
phenotype these patients. A similar large study has also
shown that individuals with chronic bronchitis have thicker
airways than those without.29
Hasegawa et al30 demonstrated, using CT scans with
seven times more radiation than used in this study, that
airway wall dimensions are associated with airflow limita-
tion and that the strength of this association increases in
more distal airways. We did not show a significant rela-
tionship between airway dimensions and FEV1. When
assessing the distal airways, we were only able to measure
to the 6th generation in around two thirds of patients, due
to obliteration by emphysematous change or inability to
establish a suitable lumen. The use of low dose CT scanning
in our study may be a reason for the lack of association
between airway wall thickness and lung function, and
between distal airways and any clinical features. However,
a low dose scan protocol can accurately assess larger
Table 2 CT measures of airway dimensions (mean of right upper and lower lobe bronchi) and lung density (%LAA).
Mean  standard deviation given for normally distributed data, median (interquartile range) is provided otherwise (indicated *).
Percentage wall area (%WA), wall thickness and luminal diameter are shown for all airway generations. Data for the 5th and 6th
generation airways were not obtainable in all cases.
Airway Generation Diameter (mm) Wall Thickness (mm) %Wall Area n
1 14.7  1.9 3.2  1.0 50  8 56
2 11.0  1.5 2.5  0.7 52  7 56
3 4.1  0.8 2.0  0.4 74  4 56
4 3.0  0.7 1.7  0.3 78  4 56
5 2.2  0.5 1.5  0.3 82  3 52
6 1.9  0.5 1.4  0.2 84  4 35
Lung Density - %Low Attenuation Areas * (n Z 56)
6.8 (1.7e19.3)
Table 3 Univariate associations between clinical and CT measured parameters [airway wall dimensions (%WA) and emphy-
sema severity (%LAA)]. For continuous data, Pearson’s correlation coefficient was used unless non-parametric (denoted #) then
Spearman’s Rho. Dichotomous data were analysed using a t-test; mean difference in %WA for each group is provided.
%Wall area by Airway Generation % Low attenuation areas(%LAA)
Proximal
1st and 2nd
Distal
3rd to 6th
% Low attenuation areas 0.30* 0.32* e
FEV1% predicted 0.03 0.06 0.52***
Smoking, pack years 0.07 0.03 0.06
Body mass index, kg/m2 # 0.27* 0.16 0.48*
Six minute walking distance, metres 0.24 0.08 0.04
St George’s Respiratory Questionnaire Total 0.37** 0.18 0.20
Exacerbations 0e1 48.8* 76.8 1.41
2 53.0* 77.9 1.87
MRC Dyspnoea Score # 0.26 0.05 0.24
Symptoms of chronic bronchitis Absent 48.0** 77.1 1.56
Present 53.5** 77.5 1.86
*p < 0.05, **p < 0.01 and ***p < 0.001.
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proximal airway dimensions (which we have found relate to
clinical parameters) and make assessment of lung density;
the additional advantage of minimising radiation dose is
useful for longitudinal studies. Nakano et al9 demonstrated
that measurement of larger more proximal airways can
provide a useful surrogate of the airway dimensions
distally, since any pathological process causing airflow
limitation within the airways is likely to occur at all
levels.31 That study used a combination of CT and lung
morphometric measurements in the correlation between
large and small airways. Like Nakano, we suspect that the
more accurate larger airway measures assessed by CT are
representative of distal airway dimensions which, despite
being pathologically significant, are beyond the scope of
our CT measuring technique.
While this is one of the first studies relating CT measured
airway dimensions to clinical features of COPD, other
groups have related CT measurements of emphysema
severity to clinical features of the disease. We have
previously reported a close relationship between emphy-
sema severity and BMI.25 Makita et al. also showed that
individuals with severe emphysema scored visually had
a lower BMI and worse health related quality of life than
those with mild emphysema, even selecting those with the
same degree of airflow limitation.32 Interestingly, like our
cohort, there was no difference in chronic bronchitic
symptoms between those two groups. Ogawa et al. also
reported a negative correlation between BMI and emphy-
sema.33 Although the relationship between BMI and airway
wall thickness was non-significant in that study, the trend
was to a positive association. In addition, similar to our
study, Patel and colleagues showed no relationship
between emphysema severity on CT and exacerbation
frequency.29 We also found a highly significant negative
correlation between airway dimensions and emphysema
severity. Such an association has previously been described
in two large studies27,29 and it has been suggested as
a mechanism for separating individuals into either an
airways or an emphysema phenotype.
Limitations
There currently is no consensus on the best means to
identify and label the airway tree. We opted to manually
ascertain airway paths; this reduces the need for more
sophisticated software but does raise the possibility of
observer bias. Our reproducibility data however indicate
this was not a major problem. Indeed other investigators
have been unable to analyse airway data by generation as
a consequence of inaccuracy in fully automated airway
mapping.34 The FWHM technique has been shown here and
by other authors to overestimate %WA. However, our vali-
dation testing found the associated measurement errors to
be within acceptable limits (see online supplement).
Table 4 Regression analyses of clinical features of COPD and both airway wall thickness and emphysema severity.
Multiple Linear Regression
Body mass index Change in BMI Confidence interval p-value
%Wall area 0.25 0.002 to 0.49 0.049
%Low attenuation areas 1.788 2.85 to 0.73 0.001
Age 0.00 0.18 to 0.18 0.99
Sex 0.18 2.89 to 0.63 0.46
Height 0.16 0.04 to 0.36 0.12
r2 Z 0.36, p < 0.001
Total St George’s Respiratory Questionnaire Change in SGRQ Confidence interval p-value
%Wall area 1.47 0.66 to 2.28 0.001
%Low attenuation areas 4.51 1.01 to 8.01 0.013
Age 0.34 0.93 to 0.25 0.26
Sex 2.82 12.28 to 17.91 0.71
Height 0.001 0.66 to 0.66 0.99
r2 Z 0.26, p Z 0.008
Binary Logistic Regression
Frequent exacerbations Odds ratio Confidence interval p-value
%Wall area 1.15 1.03 to 1.29 0.017
%Low attenuation areas 1.61 0.99 to 2.64 0.055
Age 0.93 0.86 to 1.00 0.053
Sex 2.23 0.34 to 14.66 0.41
Height 0.94 0.86 to 1.03 0.19
chi-squared Z 15.4, 5df, p Z 0.009
Symptoms of chronic bronchitis Odds ratio Confidence interval p-value
%Wall area 1.22 1.07 to 1.39 0.003
%Low attenuation areas 1.57 0.96 to 2.56 0.071
Age 0.98 0.91 to 1.05 0.504
Sex 0.52 0.074 to 3.63 0.508
Height 1.04 0.95 to 1.13 0.418
chi-squared Z 13.8, 5df, p Z 0.016
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Conclusions
In this study we have used novel software to measure
airway wall dimensions and emphysema with low dose
thoracic CT scanning in individuals with COPD. Airways of
less than 2 mm in diameter which are, in part, responsible
for airflow limitation in COPD are still beyond the scope of
this low dose CT measurement. We have shown that CT
measured airway dimensions in the larger, more proximal
airways are associated with clinical measures of COPD
independent of emphysema severity. Specifically, these
clinical features, including symptoms of chronic bronchitis,
exacerbation frequency and total St George’s score seem to
group individuals with thicker airways into a bronchitic
phenotype.
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